Studies have implicated S100A8 and S100A9 in the initiation and progression of immunoinflammatory diseases, including autoimmune synovitis, Sjögren’s syndrome, arthritis, systemic sclerosis and systemic lupus erythematosus. Here, S100A9 is linked to systemic lupus erythematosus.